Brandon Fultz

Analyst

HC Wainwright & Co.

Equibles does not estimate personal net worth.

About Brandon Fultz

Brandon Fultz is recorded as Analyst at HC Wainwright & Co.. Brandon Fultz has spoken on 2 earnings calls across 2 companies, most recently for Milestone Pharmaceuticals Inc. on November 13, 2026. Those appearances were for Milestone Pharmaceuticals Inc. (MIST) and Collegium Pharmaceutical, Inc (COLL). The companies whose calls Brandon Fultz spoke on are classified in the Healthcare sector.

Brandon Fultz on recent calls

“Do you have any insight into whether physicians are predominantly prescribing Cardamist to patients with frequent PSVT episodes or sort of starting it on the more milder, less frequent episode patient?”

Analyst — H.C. Wainwright, Third Quarter 2026 Financial Results · November 13, 2026

“Maybe just two from me. you know granted it's early but can you provide any feedback that you're hearing from field reps and prescribers about the distinctions in selling both Astaris and Jornay you know are prescribers comfortable with the different differentiation at this time or does it take a bit of discussion and…”

Analyst — HC Wainwright & Co., Q2 2026 Collegium Pharmaceutical, Inc. Earnings Conference Call · August 6, 2026